Juan Carlos Balandrán

8PUBLICATIONS
25CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursInnate immunityHaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 26, 2026
Human Mesenchymal Stromal Cells from Bone Marrow and Neonatal Sources: A Comparative In Vitro Study of Their Myelopoietic and Lymphopoietic Supportive Capacity from Hematopoietic Progenitor Cells.

|Jan 11, 2024
The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms.

Dalia Barrios-Palacios, Jorge Organista-Nava, Juan Carlos Balandrán

|Apr 13, 2023
The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms.

Juan Carlos Balandrán, Audrey Lasry, Iannis Aifantis

|Jun 08, 2022
Emergency Hematopoiesis in the Pathobiology of COVID-19: The Dark Side of an Early Innate Protective Mechanism.

Juan Carlos Balandrán, Gabriela Zamora-Herrera, Rubí Romo-Rodríguez

|Feb 25, 2022
VCAM1 confers innate immune tolerance on haematopoietic and leukaemic stem cells.

Sandra Pinho, Qiaozhi Wei, Maria Maryanovich

|Jul 02, 2020
Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico.

Gerardo Juárez-Avendaño, Nuria Citlalli Luna-Silva, Euler Chargoy-Vivaldo

Pageof 2

Frequent Collaborators

1 joint publications

Charalampos Lazaris

1 joint publications

Monica L Guzman

1 joint publications

Aristotelis Tsirigos

1 joint publications

Dalia Ramírez-Ramírez